Skip to main content
. 2021 May 5;159(5):2123–2128. doi: 10.1016/j.chest.2021.03.045

e-Table 11.

Characteristics of BODE group (score 0-2) compared to equally-sized MLMP-COPD mortality risk group

BODE group Model group p-value
No. 1589 1589
Age, mean (SD), y 63.44 (8.57) 60.31 (8.11) <0.001
Race, African American, No. (%) 166 (10.4) 233 (14.7) <0.001
Sex, female, No. (%) 603 (37.9) 696 (43.8) 0.001
Total dead, No. (%) 216 (13.6) 163 (10.3) 0.004
Days followed up, median (IQR) 2530.00 [2189.00, 2895.00] 2530.00 [2199.00, 2834.00] 0.885
BODE, median (IQR) 1.00 [0.00, 2.00] 1.00 [0.00, 2.00] <0.001
6-minute walk distance, mean (SD), ft 1458.03 (273.13) 1471.93 (289.34) 0.164
FEV1 % predicted, median (IQR) 65.00 [55.20, 71.60] 63.90 [53.80, 71.50] 0.064
mMRC dyspnea score, No. (%) <0.001
 0 623 (39.2) 536 (33.7)
 1 608 (38.3) 430 (27.1)
 2 286 (18.0) 311 (19.6)
 3 72 (4.5) 229 (14.4)
 4 0 (0.0) 83 (5.2)
FEV1/FVC ratio, median (IQR) 0.57 [0.48, 0.63] 0.58 [0.49, 0.64] 0.002
FEF25%-75%, median (IQR), L 0.68 [0.47, 0.95] 0.69 [0.48, 0.97] 0.201
Resting SaO2, median (IQR) 96.00 [94.00, 97.00] 96.00 [95.00, 97.00] 0.003
Exacerbation frequency, mean (SD), No./yr 0.41 (0.84) 0.40 (0.85) 0.866
Pack-years cigarette smoking, median (IQR) 44.00 [32.20, 60.00] 42.00 [31.00, 57.90] 0.002
BMI, mean (SD), kg/mˆ2 27.75 (5.01) 28.60 (5.91) <0.001
Severe Exacerbations, No. (%) 156 (9.8) 143 (9.0) 0.466
PA:A ratio, mean (SD) 0.88 (0.13) 0.86 (0.12) 0.009
Pi10, mean (SD) 3.90 (0.37) 3.84 (0.33) <0.001
Diabetes, No. (%) 149 (9.4) 140 (8.8) 0.622
% LAA < -950 HU, median (IQR) 6.24 [2.21, 14.67] 5.02 [1.78, 13.28] 0.001